Cargando…

Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma

Marginal zone lymphoma (MZL) is a rare, slow-growing/indolent B cell lymphoid neoplasm accounting for 10.5% to 11.8% of all B cell lymphomas. MZL originates from the mature B lymphocytes, which are usually present in the marginal zone of the lymphoid follicle. Histological transformation (HT) is def...

Descripción completa

Detalles Bibliográficos
Autores principales: Veeraballi, Sindhusha, Mirza, Noreen, Khawar, Zaineb, Shaaban, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363686/
https://www.ncbi.nlm.nih.gov/pubmed/35967131
http://dx.doi.org/10.7759/cureus.26738
_version_ 1784764982314926080
author Veeraballi, Sindhusha
Mirza, Noreen
Khawar, Zaineb
Shaaban, Hamid
author_facet Veeraballi, Sindhusha
Mirza, Noreen
Khawar, Zaineb
Shaaban, Hamid
author_sort Veeraballi, Sindhusha
collection PubMed
description Marginal zone lymphoma (MZL) is a rare, slow-growing/indolent B cell lymphoid neoplasm accounting for 10.5% to 11.8% of all B cell lymphomas. MZL originates from the mature B lymphocytes, which are usually present in the marginal zone of the lymphoid follicle. Histological transformation (HT) is defined as sheets of large cells arising in an indolent lymphoma with morphological and immunophenotypic changes suggestive of a high-grade lymphoma such as Hodgkin's lymphoma, diffuse large B cell lymphoma (DLBCL), or Burkitt lymphoma. The median time of transformation ranges from one year to 15 years following the initial diagnosis of MZL. Studies reported that the deletion of TP53 and 7q and mutations in NOTCH2 are commonly associated with HT in MZL. This case report outlines the rare happening of an MZL transformation into a nodular subtype of Hodgkin's lymphoma in a 56-year-old female, which prompted further investigations and a different therapeutic approach. By reporting this case, we emphasize that HT changes the natural history and significantly affects the overall survival of patients with MZL. Hence, it is necessary to get a core needle or excisional biopsy whenever there is a clinical suspicion of HT in MZL for early diagnosis and a better therapeutic approach.
format Online
Article
Text
id pubmed-9363686
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-93636862022-08-11 Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma Veeraballi, Sindhusha Mirza, Noreen Khawar, Zaineb Shaaban, Hamid Cureus Internal Medicine Marginal zone lymphoma (MZL) is a rare, slow-growing/indolent B cell lymphoid neoplasm accounting for 10.5% to 11.8% of all B cell lymphomas. MZL originates from the mature B lymphocytes, which are usually present in the marginal zone of the lymphoid follicle. Histological transformation (HT) is defined as sheets of large cells arising in an indolent lymphoma with morphological and immunophenotypic changes suggestive of a high-grade lymphoma such as Hodgkin's lymphoma, diffuse large B cell lymphoma (DLBCL), or Burkitt lymphoma. The median time of transformation ranges from one year to 15 years following the initial diagnosis of MZL. Studies reported that the deletion of TP53 and 7q and mutations in NOTCH2 are commonly associated with HT in MZL. This case report outlines the rare happening of an MZL transformation into a nodular subtype of Hodgkin's lymphoma in a 56-year-old female, which prompted further investigations and a different therapeutic approach. By reporting this case, we emphasize that HT changes the natural history and significantly affects the overall survival of patients with MZL. Hence, it is necessary to get a core needle or excisional biopsy whenever there is a clinical suspicion of HT in MZL for early diagnosis and a better therapeutic approach. Cureus 2022-07-11 /pmc/articles/PMC9363686/ /pubmed/35967131 http://dx.doi.org/10.7759/cureus.26738 Text en Copyright © 2022, Veeraballi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Veeraballi, Sindhusha
Mirza, Noreen
Khawar, Zaineb
Shaaban, Hamid
Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
title Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
title_full Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
title_fullStr Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
title_full_unstemmed Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
title_short Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
title_sort splenic marginal zone lymphoma with histological transformation to hodgkin’s lymphoma
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363686/
https://www.ncbi.nlm.nih.gov/pubmed/35967131
http://dx.doi.org/10.7759/cureus.26738
work_keys_str_mv AT veeraballisindhusha splenicmarginalzonelymphomawithhistologicaltransformationtohodgkinslymphoma
AT mirzanoreen splenicmarginalzonelymphomawithhistologicaltransformationtohodgkinslymphoma
AT khawarzaineb splenicmarginalzonelymphomawithhistologicaltransformationtohodgkinslymphoma
AT shaabanhamid splenicmarginalzonelymphomawithhistologicaltransformationtohodgkinslymphoma